BR9813897A - Biphenyl derivatives as pharmacists - Google Patents

Biphenyl derivatives as pharmacists

Info

Publication number
BR9813897A
BR9813897A BR9813897-9A BR9813897A BR9813897A BR 9813897 A BR9813897 A BR 9813897A BR 9813897 A BR9813897 A BR 9813897A BR 9813897 A BR9813897 A BR 9813897A
Authority
BR
Brazil
Prior art keywords
pharmacists
biphenyl derivatives
derivatives
pharmaceuticals
biphenyl
Prior art date
Application number
BR9813897-9A
Other languages
Portuguese (pt)
Inventor
Esteban Pombo Villar
Manuel Koller
Silvio Ofner
Robert Swoboda
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723133.6A external-priority patent/GB9723133D0/en
Priority claimed from GBGB9723134.4A external-priority patent/GB9723134D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9813897A publication Critical patent/BR9813897A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE BIFENILA COMO FARMACêUTICOS"<D>. Compostos de fórmula I Em que R~ 1~, R~ 2~, R~ 3~, R~ 4~ e R~ 5~ são conforme definidos na descrição, são úteis como farmacêuticos.Invention Patent: <B> "BYPHENYL DERIVATIVES AS PHARMACEUTICALS" <D>. Compounds of formula I Where R ~ 1 ~, R ~ 2 ~, R ~ 3 ~, R ~ 4 ~ and R ~ 5 ~ are as defined in the description, they are useful as pharmaceuticals.

BR9813897-9A 1997-11-03 1998-10-30 Biphenyl derivatives as pharmacists BR9813897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9723133.6A GB9723133D0 (en) 1997-11-03 1997-11-03 Organic compounds
GBGB9723134.4A GB9723134D0 (en) 1997-11-03 1997-11-03 Organic compounds
PCT/EP1998/006880 WO1999023073A1 (en) 1997-11-03 1998-10-30 Biphenyl derivatives as pharmaceuticals

Publications (1)

Publication Number Publication Date
BR9813897A true BR9813897A (en) 2000-09-26

Family

ID=26312535

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813897-9A BR9813897A (en) 1997-11-03 1998-10-30 Biphenyl derivatives as pharmacists

Country Status (18)

Country Link
EP (1) EP1037876A1 (en)
JP (1) JP2001521923A (en)
KR (1) KR20010031699A (en)
CN (1) CN1278249A (en)
AR (1) AR016148A1 (en)
AU (1) AU740448B2 (en)
BR (1) BR9813897A (en)
CA (1) CA2308151A1 (en)
CO (1) CO5011067A1 (en)
ID (1) ID24413A (en)
IL (1) IL135580A0 (en)
NO (1) NO20002321D0 (en)
NZ (1) NZ503815A (en)
PE (1) PE123599A1 (en)
PL (1) PL339922A1 (en)
SK (1) SK6412000A3 (en)
TR (1) TR200001122T2 (en)
WO (1) WO1999023073A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041280B2 (en) 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6858592B2 (en) 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
TW200840566A (en) * 2006-12-22 2008-10-16 Esteve Labor Dr Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
WO2010059393A1 (en) 2008-10-30 2010-05-27 Janssen Pharmaceutica Nv Serotonin receptor modulators
US8575364B2 (en) * 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor
DE102009015697A1 (en) 2009-03-31 2010-10-07 Markus Dr. Heinrich Process for the arylation of ring-substituted phenols and phenyl ethers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2114122A (en) * 1938-04-12 Alcohols and process fob making
DE674968C (en) * 1935-01-15 1939-04-26 Roehm & Haas Company Process for the preparation of phenolic aralkylamino alcohols
US2040039A (en) * 1935-02-26 1936-05-05 Rohm & Haas Phenolic morpholines
US2485550A (en) * 1946-06-25 1949-10-25 Hoffmann La Roche Quaternary salts of carbamic acid esters of tertiary-hydroxybenzyl-amines
US2493710A (en) * 1947-03-21 1950-01-03 Hoffmann La Roche Carbamic acid esters
US2872477A (en) * 1957-04-05 1959-02-03 Dow Chemical Co alpha-(dialkylamino)-6-phenyl-o-cresol esters
JPS5328150A (en) * 1976-08-25 1978-03-16 Sugai Chemical Ind Co Ltd Novel orthophenyl phenol derivative process for preparing same
EP0382213B1 (en) * 1989-02-08 1995-05-10 Otsuka Pharmaceutical Co., Ltd. Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases
JPH072655A (en) * 1993-06-18 1995-01-06 Otsuka Pharmaceut Co Ltd Agent for repairing or protecting denaturation of peripheral nerve
ATE210657T1 (en) * 1994-10-14 2001-12-15 Merck Patent Gmbh CNS EFFECTIVE (R)-(-)-2-(5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL)CHROMANE
WO1996016058A1 (en) * 1994-11-23 1996-05-30 Neurogen Corporation Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
IL116249A (en) * 1994-12-12 2003-07-06 Pfizer Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
DE19637237A1 (en) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazine derivatives

Also Published As

Publication number Publication date
CA2308151A1 (en) 1999-05-14
WO1999023073A1 (en) 1999-05-14
NZ503815A (en) 2002-05-31
CO5011067A1 (en) 2001-02-28
NO20002321L (en) 2000-05-02
AU740448B2 (en) 2001-11-01
IL135580A0 (en) 2001-05-20
AR016148A1 (en) 2001-06-20
ID24413A (en) 2000-07-20
CN1278249A (en) 2000-12-27
PL339922A1 (en) 2001-01-15
EP1037876A1 (en) 2000-09-27
TR200001122T2 (en) 2000-08-21
PE123599A1 (en) 1999-12-20
NO20002321D0 (en) 2000-05-02
KR20010031699A (en) 2001-04-16
SK6412000A3 (en) 2000-09-12
JP2001521923A (en) 2001-11-13
AU1487299A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
BR0208338A (en) Pyridine Derivatives
PT911333E (en) PYRAZOLINE-4,3-D | PYRIMIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR0111981A (en) substituted pyridine herbicides
BR0308211A (en) Coumarins Useful as Biomarkers
BR9811685A (en) Pyridine derivatives
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
BR0108713A (en) Hybrid Expression of Neisserial Proteins
BR0209129A (en) Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds.
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
BR0010220A (en) Pyrimidinone compounds
TR200102800T2 (en) New compounds.
BR0207278A (en) Phthalazinone-piperidine derivatives as pde4 inhibitors
BR9808491A (en) Calcilic compounds
BR9713338A (en) Benzonaphyridines as bronchial therapeutics.
DK0842934T3 (en) 5-HT1F agonists
IT1285770B1 (en) CORTICOID COMPOUNDS
BR0109542A (en) Alkylated imidazopyrine derivatives
MY133969A (en) Indoloquinazolinones
BR0209128A (en) Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds
SE9801494D0 (en) Novel use
BR9807988A (en) Process for the preparation of a compound, e, compound.
TR200001102T2 (en) Substituted tetrahydropyrimidinene derivatives, their production and uses.
BR9705456A (en) Heterocyclic compounds, aminomethyl process for their preparation and pharmaceutical compositions that contain them.
BRPI0415285A (en) aminoalcanol derivatives
BR9813897A (en) Biphenyl derivatives as pharmacists

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.